O ṣeun fun lilo si Nature.com. Ẹya ẹrọ aṣawakiri ti o nlo ni atilẹyin CSS lopin. Fun iriri ti o dara julọ, a ṣeduro pe ki o lo ẹrọ aṣawakiri imudojuiwọn kan (tabi mu Ipo Ibamu ṣiṣẹ ni Internet Explorer). Lakoko, lati rii daju pe atilẹyin tẹsiwaju, a yoo ṣe aaye naa laisi awọn aza ati JavaScript.
Awọn peptides ati awọn ọlọjẹ ti wa ni lilo pupọ lati tọju ọpọlọpọ awọn arun, ṣugbọn wọn nigbagbogbo ni abẹrẹ ati ipa wọn jẹ igba diẹ. Awọn ailagbara wọnyi ti awọn ẹya abinibi le yọkuro pẹlu iranlọwọ ti imọ-ẹrọ molikula, ṣugbọn eyi jẹ iṣẹ ti o nira. Awọn imọ-ẹrọ imọ-ẹrọ molikula, ni akọkọ ti a lo si hisulini ati ni bayi ti a lo ni aṣeyọri si ọpọlọpọ awọn biopharmaceuticals, nilo itọsẹ ti awọn peptides ati awọn ọlọjẹ lati awọn acids fatty. Awọn abuda kan pato ati ipo ti awọn acids fatty ti a so le pese awọn ọna ṣiṣe elongation oriṣiriṣi. Ni afikun, imọ-ẹrọ yii le pese igbesi aye idaji gigun lẹhin iṣakoso ẹnu ti awọn oogun peptide, le paarọ pinpin awọn peptides, ati pe o le ni agbara fun ifọkansi àsopọ. Pẹlu ailewu atorunwa ti awọn acids fatty ati awọn ohun-ini kemikali ti o ni alaye daradara, imọ-ẹrọ yii n pese ọna ti o wapọ si peptide ati wiwa oogun amuaradagba.
Gbogbo iye owo wa net. VAT yoo wa ni afikun nigbamii ni ibi isanwo. Awọn iṣiro owo-ori yoo ṣee ṣe ni ibi isanwo.
Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Trends ni peptide oògùn Awari. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Trends ni peptide oògùn Awari.Muttenthaler, M., King, GF, Adams, DJ ati Alevud, PF Trends ni peptide oògùn Awari. Muttenthaler, M., Ọba, GF, Adams, DJ & Alewood, PF 多肽药物发现的趋势。 Muttenthaler, M., Ọba, GF, Adams, DJ & Alewood, PFMuttenthaler, M., King, GF, Adams, DJ ati Alevud, PF Trends ni peptide oògùn Awari.Orilẹ-ede šiši Aguntan oogun. 20, 309-325 (2021). Atunwo yii da lori lọwọlọwọ ati awọn aaye iwaju ti iṣawari oogun peptide.
Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Anti-isanraju oogun Awari: awọn ilọsiwaju ati awọn italaya. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Anti-isanraju oogun Awari: awọn ilọsiwaju ati awọn italaya.Müller, TD, Blucher, M., Chop, MH ati DiMarchi, RD Anti-isanraju oogun Awari: ilọsiwaju ati awọn italaya. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD 抗肥胖药物发现：进展和挑战。 Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RDMüller, TD, Blucher, M., Chop, MH ati DiMarchi, RD Anti-isanraju oogun Awari: ilọsiwaju ati awọn italaya.Orilẹ-ede šiši Aguntan oogun. Ọdun 21, 201–223 (2022). Atunwo yii n pese oye sinu awọn iṣoro ti isanraju, paapaa awọn imọran tuntun ti o da lori awọn peptides.
Strohl, awọn ọlọjẹ Fusion WR lati faagun idaji-aye ti awọn onimọ-jinlẹ bi ilana ti o dara julọ fun awọn onimọ-jinlẹ. Biopharmaceutics 29, 215-239 (2015).
Evans, M. et al. Ifaramọ ati itẹramọṣẹ ti awọn oogun antidiabetic ati ajọṣepọ pẹlu ile-iwosan ati awọn abajade eto-ọrọ ni awọn alaisan ti o ni àtọgbẹ iru 2: atunyẹwo eto ti awọn iwe. isanraju dayabetik. iṣelọpọ agbara. Ọdun 24, 377–390 (2022).
Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Patient irisi lori lẹẹkan-ọsẹ oogun fun àtọgbẹ. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Patient irisi lori lẹẹkan-ọsẹ oogun fun àtọgbẹ.Polonsky WH, Fisher L., Hessler D., Brune D., Ati Ti o dara ju JH Iwoye alaisan kan lori awọn oogun alakan-ọsẹ-ẹẹkan. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH 患者对每周一次的糖尿病药物的看法。 Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Dara julọ, JHPolonsky WH, Fisher L., Hessler D., Brune D., Ati Iro Alaisan JH ti o dara julọ ti awọn oogun alakan-ọsẹ-ẹẹkan.isanraju dayabetik. iṣelọpọ agbara. Ọdun 13, 144–149 (2011).
Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Agbepọ ti awọn itọsẹ palmitoyl ti hisulini ati awọn iṣẹ ibi-aye wọn. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Agbepọ ti awọn itọsẹ palmitoyl ti hisulini ati awọn iṣẹ ibi-aye wọn.Hashimoto M., Takada K., Kiso Y. ati Muranishi S. Agbepọ ti awọn itọsẹ palmitoyl ti hisulini ati iṣẹ ṣiṣe ti ara wọn. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性。 Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis ati iṣẹ ṣiṣe ti ẹda ti awọn itọsẹ insulin palmitoyl.Hashimoto M., Takada K., Kiso Y. ati Muranishi S. Iṣagbepọ ati iṣẹ ṣiṣe ti ẹda ti awọn itọsẹ insulin palmitoyl.ifiomipamo oogun 6, 171-176 (1989).
Kurtzhals, P. et al. Abuda Albumin si hisulini acid acid-fatty: ijuwe ti awọn ibaraenisepo amuaradagba ligand-amuaradagba ati ibaraenisepo laarin isunmọ abuda ati akoko iṣe insulin ni vivo. biochemu. J. 312, 725–731 (1995). Iṣẹ yii jẹ akọkọ lati ṣe afihan ilosoke ninu igbesi aye idaji nitori sisopọ albumin si awọn peptides ti o wa lati awọn acids fatty.
Mejuch, T. & Waldmann, H. Akopọ ti awọn ọlọjẹ lipidated. Mejuch, T. & Waldmann, H. Akopọ ti awọn ọlọjẹ lipidated.Meyukh, T. ati Waldmann, H. Akopọ ti awọn ọlọjẹ lipidated. Mejuch, T. & Waldmann, H. 脂化蛋白质的合成。 Mejuch, T. & Waldmann, H.Meyukh, T. ati Waldmann, H. Akopọ ti awọn ọlọjẹ lipidated.Bioconjugate. Kemikali. Ọdun 27, 1771–1783 (2016).
Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein lipidation in cell signaling and disease: iṣẹ, ilana, ati awọn anfani iwosan. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein lipidation in cell signaling and disease: iṣẹ, ilana, ati awọn anfani iwosan.Chen B., Sun Y., Niu J., Jarugumilli GK ati Wu X. Amuaradagba lipidation ni ifihan sẹẹli ati arun: iṣẹ, ilana, ati agbara itọju ailera. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein 脂化 ni ifihan sẹẹli ati arun: iṣẹ, ilana ati awọn anfani iwosan.Chen B., Sun Y., Niu J., Jarugumilli GK ati Wu X. Amuaradagba lipidation ni ifihan sẹẹli ati arun: iṣẹ, ilana, ati agbara itọju ailera.cytokemistri. isedale 25, 817-831 (2018).
Richter, WF, Bhansali, SG & Morris, ME Mechanistic ipinnu gbigba biotherapeutics ni atẹle iṣakoso SC. Richter, WF, Bhansali, SG & Morris, ME Mechanistic ipinnu gbigba biotherapeutics ni atẹle iṣakoso SC.Richter, VF, Bhansali, SG ati Morris, Awọn ilana ME ti o pinnu gbigba ti awọn aṣoju biotherapeutic lẹhin iṣakoso abẹ-ara. Richter, WF, Bhansali, SG & Morris, ME SC 给药后生物治疗药物吸收的机制决定因素。 Richter, WF, Bhansali, SG & Morris, ME SC Richter, WF, Bhansali, SG & Morris, ME SC Механистические детерминанты абсорбции Richter, WF, Bhansali, SG & Morris, ME SC Mechanistic ipinnu ti gbigba ti awọn oogun biotherapeutic lẹhin iṣakoso.AAPS J. 14, 559-570 (2012).
Gradel, AKJ et al. Awọn okunfa ti o kan gbigba insulin subcutaneous: awọn ilolu fun iyatọ. J. Àtọgbẹ Res. Ọdun 2018, 1205121 (2018).
Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion ati polymerization pinnu gbigba hisulini lati inu àsopọ abẹ awọ ara ni awọn alaisan alakan. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion ati polymerization pinnu gbigba hisulini lati inu àsopọ abẹ awọ ara ni awọn alaisan alakan. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и пределяют пациентов с диабетом. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion ati polymerization pinnu gbigba hisulini lati inu àsopọ abẹ awọ ara ni awọn alaisan alakan. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и агрегация. пациентов с диабетом. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Itankale ati ikojọpọ pinnu gbigba insulin subcutaneous ni awọn alaisan alakan.wíwo. J. Klin. yàrá. nawo. 45, 685-690 (1985).
Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Awoṣe gbigba kainetik ti subcutaneous itasi tiotuka insulin. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Awoṣe gbigba kainetik ti subcutaneous itasi tiotuka insulin.Mosekilde E, Jensen KS, Binder S, Pramming S, ati Thorsteinsson B. Awoṣe awọn kainetik gbigba ti hisulini soluble subcutaneous. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. 模拟皮下注射可溶性胰岛素的吸收动力学。 Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B.Mosekilde E, Jensen KS, Binder S, Pramming S, ati Thorsteinsson B. Awoṣe awọn kainetik gbigba ti hisulini tiotuka ti a nṣakoso labẹ awọ ara.J. Pharmacokinetics. biopharmacy. Ọdun 17, 67–87 (1989).
Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Iwọn Molecular ṣe atunṣe awọn elegbogi elegbogi, ipinpinpin-ara, ati ifisilẹ kidirin ti ifijiṣẹ oogun biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Iwọn Molecular ṣe atunṣe awọn elegbogi elegbogi, ipinpinpin-ara, ati ifisilẹ kidirin ti ifijiṣẹ oogun biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Размер молекулы. биополимерногo эlastynopodobnoho polipeptida fun awọn ọmọ-ọwọ lekarstvennoho sredstva. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Iwọn Molecular ṣe atunṣe awọn oogun elegbogi, ipinpinpin-ara, ati ifisilẹ kidirin ti biopolymeric elastin-like polypeptide fun ifijiṣẹ oogun. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III分子大小调节药物递送生物聚合物弹性蛋白样多肽的药代动力学、生物分分生物分。 Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecule 大小名行电影送送 biological polymer elastic protein sampleKuna, M., Mahdi, F., Chad, AR ati Bidwell, GL III. Pharmacokinetics, ipinpinpin ipinpinpin ati ifisilẹ kidirin ti biopolymeric elastin-bi polypeptides ti n ṣatunṣe iwọn moleku naa.Imọ Iroyin 8, 7923 (2018).
Harris, JM, Martin, NE & Modi, M. Pegylation: ilana aramada fun iyipada awọn oogun elegbogi. Harris, JM, Martin, NE & Modi, M. Pegylation: ilana aramada fun iyipada awọn oogun elegbogi. Harris, JM, Martin, NE & Modi, M. Harris, JM, Martin, NE & Modi, M. Pegylation: ilana aramada fun iyipada awọn oogun elegbogi. Harris, JM, Martin, NE & Modi, M. 聚乙二醇化：一种改变药代动力学的新方法。 Harris, JM, Martin, NE & Modi, M. 聚乙二感化: ọna tuntun ti iyipada oogun. Harris, JM, Martin, NE & Modi, M. Пегилирование: Harris, JM, Martin, NE & Modi, M. Pegylation: ọna tuntun si iyipada awọn oogun elegbogi.isẹgun. Pharmacokinetics. 40, 539-551 (2001).
Elmerer, M. et al. Wiwọn albumin interstitial ninu iṣan egungun eniyan ati adipose tissue nipasẹ ṣiṣi microperfusion ṣiṣan. Bẹẹni. J. Fisioloji. endocrine. iṣelọpọ agbara. 278, E352-E356 (2000).
Nelson, J. et al. Igbesi aye idaji gigun ti albumin ninu eniyan nilo C-terminus ti ko tọ. ibaraẹnisọrọ. isedale. 3, 181 (2020).
Chowdhury, K. et al. Olugba Fc (FcRn) fun IgG ti o ni nkan ṣe pẹlu eka pataki histocompatibility nsopọ albumin ati ki o fa igbesi aye rẹ gun. J. Exp. òògùn. Ọdun 197, 315-322 (2003).
Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ti IgG gẹgẹbi alajaja nipasẹ olugba, FcRn: onínọmbà ni ipele ti o ni ẹyọkan. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ti IgG gẹgẹbi alajaja nipasẹ olugba, FcRn: onínọmbà ni ipele ti o ni ẹyọkan. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Эkzotsytoz IgG, oposredovannыy awọn ilana FcRn. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES FcRn receptor-mediated IgG exocytosis: onínọmbà moleku nikan. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES 受体介导的IgG 胞吐作用，FcRn：单分子水平的分析。 Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, Эkzotsytoz IgG, oposredovannыy respeptorom ES, FcRn. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES receptor-mediated IgG exocytosis, FcRn: iṣiro-ipele ipele moleku.ilana. National Academy of Science. ijinle sayensi. US 101, 11076 (2004).
Oun, XM & Carter, DC Atomic be ati kemistri ti omi ara eniyan albumin. Oun, XM & Carter, DC Atomic be ati kemistri ti omi ara eniyan albumin.Lori, XM ati Carter, DC Atomic be ati kemistri ti ara eniyan albumin. He, XM & Carter, DC 人血清白蛋白的原子结构和化学。 Oun, XM & Carter, DC.Lori, XM ati Carter, DC Atomic be ati kemistri ti ara eniyan albumin.Iseda 358, 209-215 (1992).
Curry, S., Mandelkow, H., Brick, P. & Franks, N. Crystal be of serum albumin complexed with fatty acid ṣe afihan pinpin asymmetric ti awọn aaye abuda. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Crystal be of serum albumin complexed with fatty acid ṣe afihan pinpin asymmetric ti awọn aaye abuda.Curry S., Mandelkow H., Brick P. ati Franks N. Ilana kirisita ti omi ara albumin ni eka pẹlu acid fatty kan fihan pinpin aibaramu ti awọn aaye abuda. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Ilana kirisita ti eka amuaradagba funfun ti ara eniyan pẹlu awọn acids fatty ṣe afihan pinpin aibaramu ti awọn aaye abuda.Curry S., Mandelkow H., Brick P. ati Franks N. Ilana kirisita ti omi ara albumin ni eka pẹlu awọn acids fatty ṣe afihan pinpin aibaramu ti awọn aaye abuda.Nat. igbekale. isedale 5, 827-835 (1998). Iwe yii ṣafihan ipilẹ igbekalẹ ti didi awọn acids fatty si omi ara albumin.
Irby, D., Du, C. & Li, F. Lipid – conjugate oogun fun imudara ifijiṣẹ oogun. Irby, D., Du, C. & Li, F. Lipid – conjugate oogun fun imudara ifijiṣẹ oogun.Irby, D., Du, K. ati Li, F. Lipid-oògùn conjugates fun imudara oògùn ifijiṣẹ. Irby, D., Du, C. & Li, F. Lipid-oògùn conjugate fun imudara ifijiṣẹ oogun. Irby, D., Du, C. & Li, F. Lipid-oògùn conjugate fun imudara ifijiṣẹ oogun.Irby, D., Du, K. ati Li, F. Lipid-oògùn conjugate fun imudara oogun ifijiṣẹ.Biokemistri 14, 1325-1338 (2017).
Torchilin VP Awọn ilọsiwaju aipẹ ni aaye ti awọn liposomes bi awọn gbigbe oogun. Orilẹ-ede šiši Aguntan oogun. 4, 145-160 (2005).
Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Awọn anfani ati awọn italaya ti fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Awọn anfani ati awọn italaya ti fatty acid conjugated therapeutics.Bhat, M., Jatyan, R., Mittal, A., Mahato, RI ati Chitkara, D. Awọn anfani ati awọn italaya ti fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战。 Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Fatty acid 共续电影的机遇和 ipenija.Bhat M., Jatyan R., Mittal A., Mahato RI ati Chitkara D. Awọn anfani ati awọn italaya ti itọju ailera conjugation fatty acid.Kemikali. fisiksi Lipids 236, 105053 (2021).
Smith, R. & Tanford, C. Hydrophobicity ti gun pq n-alkyl carboxylic acids, bi a ṣe iwọn nipasẹ pinpin wọn laarin heptane ati awọn ojutu olomi. Smith, R. & Tanford, C. Hydrophobicity ti gun pq n-alkyl carboxylic acids, bi a ṣe iwọn nipasẹ pinpin wọn laarin heptane ati awọn ojutu olomi.Smith, R. ati Tanford, K. Hydrophobicity ti gigun-gun n-alkylcarboxylic acids ti a ṣe iwọn nipasẹ pinpin wọn laarin heptane ati awọn ojutu olomi. Smith, R. & Tanford, C. 长链正烷基羧酸的疏水性，通过它们在庚烷和水溶液之间的分布来测量。 Smith, R. & Tanford, C. Awọn hydrophobicity ti 长链正alkylcarboxylate, wọn nipasẹ pinpin wọn laarin hydrogen peroxide ati ojutu olomi.Smith, R. ati Tanford, K. Hydrophobicity ti gigun-gun n-alkylcarboxylic acids ti a ṣe iwọn nipasẹ pinpin wọn laarin heptane ati awọn ojutu olomi.ilana. National Academy of Sciences. ijinle sayensi US 70, 289 (1973).
Liu, J. et al. Awari-ẹẹkan-ọsẹ ti semaglutide analog ti glucagon-like peptide-1 (GLP-1). J. Oogun. Kemikali. 58, 7370-7380 (2015). Iṣẹ yii ṣe afihan fun igba akọkọ o ṣeeṣe ti lilo lẹẹkan ni ọsẹ kan awọn ọna itọsẹ acid fatty acid.
Østergaard, S. et al. Ipa eniyan PYY3-36 dibasic fatty acid acylation lori iṣẹ-ṣiṣe olugba kekere-ẹlẹdẹ Y2 ati idaji-aye. ijinle sayensi. Iroyin 11, 21179 (2021). Nkan yii ṣe afihan pataki ti ipo acid fatty, ọna asopọ ati iduroṣinṣin ẹhin ni idagbasoke awọn afọwọṣe PYY idaji gigun.
Ensenat-Vaser, R. et al. Ilaluja ti awọn peptides myristoylated kọja awọ ara sẹẹli ni a ṣe akiyesi taara ni lilo airi airi fluorescence confocal. IUBMB Igbesi aye 54, 33–36 (2002).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl gbigbe ti awọn peptides sinu awọn sẹẹli alãye. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl gbigbe ti awọn peptides sinu awọn sẹẹli alãye.Nelson AR, Borland L, Allbritton NL. ati Sims SE Peptide gbigbe ni awọn sẹẹli alãye da lori myristoyl. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中 Nelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borland, L., Albritton, NL. ati Sims, KE Transport of myristoyl-orisun peptides sinu ngbe ẹyin.Biokemistri 46, 14771-14781 (2007).
Kabanov, AV, Levashov, AV & Alakhov, VY Lipid iyipada ti awọn ọlọjẹ ati gbigbe awo awọ wọn. Kabanov, AV, Levashov, AV & Alakhov, VY Lipid iyipada ti awọn ọlọjẹ ati gbigbe awo awọ wọn.Kabanov AV, Levashov AV, Alakhov V.Yu. Iyipada ọra ti awọn ọlọjẹ ati gbigbe awo awọ wọn. Kabanov, AV, Levashov, AV & Alakhov, VY 蛋白质的脂质修饰及其膜转运. Kabanov, AV, Levashov, AV & Alakhov, VYKabanov AV, Levashov AV, Alakhov, Lipid iyipada ti awọn ọlọjẹ VY ati irinna awo awọ wọn.amuaradagba ina-. Oṣu kejila Searl. 3, 39–42 (1989).
Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation ṣe ilọsiwaju ti inu cellular ati pinpin cytosolic ti peptide cystine-knot. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation ṣe ilọsiwaju ti inu cellular ati pinpin cytosolic ti peptide cystine-knot.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. ati Hannoosh, RN Fatty acid acylation ti nmu inu inu cellular ati pinpin cytosolic ti peptide kan pẹlu lupu cystine. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Gao, X., Mazière, AD, Irungbọn, R., Klumperman, J. & Hannoush, RN.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. ati Hannoosh, RN Fatty acylation mu ki inu inu cellular ati pinpin cytoplasmic ti awọn peptides cystine.iScience 24, 103220 (2021).
Baker, EM et al. Iyipada igbesi-aye gigun-idaji ti peptide YY3-36 fun isọdi-alajaja olugba taara. Moore. òògùn. Ọdun 16, 3665–3677 (2019).
Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Ipo ati ipari ti ọra acids ni ipa ni ipa lori ilana yiyan olugba ti awọn analogues polypeptide pancreatic eniyan. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Ipo ati ipari ti ọra acids ni ipa ni ipa lori ilana yiyan olugba ti awọn analogues polypeptide pancreatic eniyan.Ṣe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. ati Beck-Sickinger, AG Ipo ati ipari ti awọn acids fatty ni ipa lori ilana yiyan ti awọn olugba afọwọṣe polypeptide pancreatic eniyan. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil'er, J. & Beck-Sickinger, AG脂肪酸的位置和长度强烈影响人胰腺多肽类似物的受体选择性模式。 Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil'er, J. & Beck-Sickinger, AGṢe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. ati Beck-Sickinger, AG Ipo ati ipari ti awọn acids fatty ni ipa lori ilana yiyan ti awọn olugba polypeptide pancreatic pancreatic eniyan.HimMedChem 9, 2463-2474 (2014).
Aleksopoulou, F. et al. Metabolite ọra PrRP31 jẹ GPR10 meji ti n ṣiṣẹ pipẹ ati agonist olugba NPFF2 pẹlu awọn ipa ipadanu iwuwo to lagbara. ijinle sayensi. Iroyin 12, 1696 (2022). Iwadi ilana yii ṣe afihan awọn iyatọ laarin mono- ati awọn ẹwọn ẹgbẹ diacid.
Poulsen, K. et al. Idagbasoke onipin ti awọn agonists iduroṣinṣin ti peptide olugba Y2 PYY3-36. òògùn. ojò ipamọ. Ọdun 38, ọdun 1369–1385 (2021).
Conde-Frieboes, K. et al. Idanimọ ati ijuwe ti in vitro ati in vivo analogues ti ṣiṣe pipẹ ati yiyan melanocortin 4 receptor (MC4-R) alpha-melanocyte-stimulating hormone (alpha-MSH). J. Oogun. Kemikali. Ọdun 55, ọdun 1969-1977 (2012).
Ramirez-Andersen, HS ati al. Awọn analogues homonu idagba eniyan ti n ṣiṣẹ pipẹ ni asopọ si albumin ti kii ṣe covalent. Bioconjugate. Kemikali. 29, 3129-3143 (2018).
Madsen, K. et al. Ibasepo iṣẹ-ṣiṣe-iṣe ati elongation ti awọn itọsẹ glucagon-bi peptide-1 ti n ṣiṣẹ pipẹ: pataki ti gigun acid fatty, polarity, ati iwọn didun. J. Oogun. Kemikali. 50, 6126-6132 (2007).
Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Double-acylated GLP-1 itọsẹ. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Double-acylated GLP-1 itọsẹ. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Дважды произванные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Awọn itọsẹ acylated meji ti GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Диацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Diacylated itọsẹ ti GLP-1.Itọsi AMẸRIKA WO2012/140117 (2012).
Ọdọmọkunrin, P.-Yu. Duro. Agbara, awọn afọwọṣe GLP-1 ti o gun-gigun ti a ṣe apẹrẹ fun ifijiṣẹ transdermal ti o da lori microstructure. ilana. National Academy of Science. ijinle sayensi. US 113, 4140-4145 (2016).
Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Iwadi ti ailewu, ifarada, pharmacokinetics, ati pharmacodynamics ti ẹyọkan ati awọn abere pupọ ti afọwọṣe α-MSH ti o gun-gun ni iwuwo ilera ati isanraju awọn koko-ọrọ. Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Iwadi ti ailewu, ifarada, pharmacokinetics, ati pharmacodynamics ti ẹyọkan ati awọn abere pupọ ti afọwọṣe α-MSH ti o gun-gun ni iwuwo ilera ati isanraju awọn koko-ọrọ.Royalty, JE, Konradsen, G., Eskerod, O., Wolf, BS ati Hansen, Aabo BS, ifarada, ile elegbogi, ati iwadi elegbogi ti ẹyọkan ati ọpọ awọn abere ti afọwọṣe α-MSG pipẹ ni iwọn apọju ilera ati awọn koko-ọrọ isanraju.版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS 单剂量和多剂量长效α-MSH类似物在健康超重和肥胖患者中的安全性、耐受性、药代动力学和药效学甑甑箩箚稱站。版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Nikan doseji ati ọpọlọpọ iwọn lilo gun ipa α-MSH全健康超重和肥胖可以中可以可以而受性、药代报学学和药效学研究科箛。Royalty, JE, Konradsen, G., Eskerod, O., Wolf, BS ati Hansen, BS Abo, ifarada, pharmacokinetics ti ẹyọkan ati ọpọ abere ti gun-anesitetiki alpha-MSG analogues ni ilera apọju iwọn ati ki o sanra. Kinetics ati pharmacodynamics.J. Clin. Pharmacodynamics. 54, 394-404 (2014).
Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogues. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogues.Lau, J., F., Kruse, T., Linderoth, L. ati Togersen, H. New glucagon analogues. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. 新型胰高血糖素类似物。 Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H.Lau, J., F., Cruz, T., Linderoth, L. ati Togersen, H. New glucagon analogues.Itọsi AMẸRIKA WO2011/117416 A1 (2011).
Ward, BP et al. Lipidation ti awọn peptides ṣe iduro awọn ẹya lati mu iṣẹ ṣiṣe ti ibi ṣiṣẹ. Moore. iṣelọpọ agbara. 2, 468-479 (2013). Iṣẹ yii ṣe afihan ipa ti awọn ẹwọn ẹgbẹ acid fatty ni ṣiṣe ipinnu iduroṣinṣin igbekalẹ ati abuda ti awọn olugba oogun peptide.
Koskun T. et al. LY3298176, aramada meji GIP ati GLP-1 agonist olugba fun itọju iru àtọgbẹ 2: lati iwari si ẹri ile-iwosan ti imọran. Moore. iṣelọpọ agbara. 18, 3-14 (2018). Iwe yii ṣe afihan apẹrẹ ti GLP-1/GIP co-agonist ti o fatty acid akọkọ fun iṣakoso lẹẹkan-ọsẹ ni ile-iwosan.
Kjeldsen, TB et al. Imọ-ẹrọ molikula ti hisulini icodec, afọwọṣe insulini acylated akọkọ ni ẹẹkan-ọsẹ ninu eniyan. J. Oogun. Kemikali. Ọdun 64, 8942–8950 (2021). Iwe yii ṣafihan idagbasoke akọkọ ti insulin fatty acid ti a mu fun iṣakoso lẹẹkan ni ọsẹ kan.
van Witteloostein, SB et al. Neoglycolipids fun awọn peptides ti n ṣiṣẹ pipẹ: awọn analogs ti ara ẹni ti glucagon-like peptide 1 pẹlu awọn ohun-ini abuda albumin ati giga ni agbara vivo. Moore. òògùn. Ọdun 14, 193–205 (2017).
Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. Acylated heptapeptide so albumin pẹlu ga ijora ati ohun elo bi tag pese gun-anesitetiki peptides. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. Acylated heptapeptide so albumin pẹlu ga ijora ati ohun elo bi tag pese gun-anesitetiki peptides.Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. ati Haynes, S. Acylated heptapeptide so albumin pẹlu ga ijora, ati awọn oniwe-lilo bi aami pese a gun-anesitetiki peptide. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 酰化七肽以高亲和力结合白蛋白，并作为栕签提以 Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 鎄化七peptide以高亲和力设计白白约筒，使用设设，使用何设论承用何设论承用设论承用井设论承用井设论承用井设论承用井设论扡承用井设认。Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. ati Haynes, S. Acylated heptapeptides dè albumin pẹlu ga ijora ati ki o sin bi aami fun gun-anesitetiki peptide ifijiṣẹ.Nat. ibasọrọ 8, 16092 (2017).